HSBC Holdings’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,448
Closed -$67.1K 2660
2025
Q1
$67.1K Sell
6,448
-9
-0.1% -$94 ﹤0.01% 2417
2024
Q4
$88.4K Sell
6,457
-108
-2% -$1.48K ﹤0.01% 2483
2024
Q3
$129K Buy
6,565
+1,508
+30% +$29.7K ﹤0.01% 2360
2024
Q2
$95.9K Hold
5,057
﹤0.01% 2372
2024
Q1
$70.9K Hold
5,057
﹤0.01% 2477
2023
Q4
$42.1K Hold
5,057
﹤0.01% 2180
2023
Q3
$45.6K Hold
5,057
﹤0.01% 2119
2023
Q2
$43.2K Sell
5,057
-390
-7% -$3.34K ﹤0.01% 2049
2023
Q1
$56.7K Sell
5,447
-1,946
-26% -$20.2K ﹤0.01% 2123
2022
Q4
$245K Buy
7,393
+2,015
+37% +$66.6K ﹤0.01% 2206
2022
Q3
$263K Buy
5,378
+2,521
+88% +$123K ﹤0.01% 2056
2022
Q2
$162K Buy
2,857
+1,397
+96% +$79.2K ﹤0.01% 2500
2022
Q1
$119K Buy
1,460
+355
+32% +$28.9K ﹤0.01% 2710
2021
Q4
$227K Buy
+1,105
New +$227K ﹤0.01% 2488
2021
Q3
Sell
-1,581
Closed -$410K 2602
2021
Q2
$410K Buy
+1,581
New +$410K ﹤0.01% 1904
2020
Q4
Sell
-1,289
Closed -$323K 2605
2020
Q3
$323K Buy
1,289
+203
+19% +$50.9K ﹤0.01% 1796
2020
Q2
$377K Buy
+1,086
New +$377K ﹤0.01% 1655
2019
Q4
Sell
-4,510
Closed -$1.23M 2513
2019
Q3
$1.23M Sell
4,510
-560
-11% -$153K ﹤0.01% 1309
2019
Q2
$2.71M Buy
5,070
+459
+10% +$245K 0.01% 972
2019
Q1
$2.32M Buy
4,611
+1,301
+39% +$656K ﹤0.01% 1046
2018
Q4
$1.63M Sell
3,310
-951
-22% -$469K ﹤0.01% 1111
2018
Q3
$3.84M Buy
4,261
+494
+13% +$445K 0.01% 867
2018
Q2
$2.76M Sell
3,767
-6,164
-62% -$4.51M ﹤0.01% 1015
2018
Q1
$15.8M Buy
+9,931
New +$15.8M 0.02% 520
2017
Q1
Sell
-1,967
Closed -$362K 1939
2016
Q4
$362K Buy
+1,967
New +$362K ﹤0.01% 1663
2015
Q3
Sell
-736
Closed -$138K 1758
2015
Q2
$138K Buy
736
+5
+0.7% +$938 ﹤0.01% 1633
2015
Q1
$121K Sell
731
-50
-6% -$8.28K ﹤0.01% 1675
2014
Q4
$182K Buy
+781
New +$182K ﹤0.01% 1382